The mode of action of progestagens on endometrial carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000378:metabolism; D000818:Animals; D001284:Atrophy / Q000378:metabolism; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004717:Endometrium / Q000166:cytology / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000378:metabolism; D008598:Menstruation; D009924:Organ Culture Techniques; D011247:Pregnancy; D011372:Progestins / Q000494:pharmacology*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D011980:Receptors, Progesterone; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000378:metabolism
D004273:DNA, Neoplasm; D011372:Progestins; D012334:RNA, Neoplasm; D011980:Receptors, Progesterone